The Genetic and Immunologic Landscape Underlying the Risk of Malignant Progression in Laryngeal Dysplasia.

TILs immune system immunity system laryngeal cancer laryngeal dysplasia tumor microenvironment tumor-infiltrating lymphocytes

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Feb 2023
Historique:
received: 27 12 2022
revised: 27 01 2023
accepted: 08 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

(1) Background: The development of laryngeal cancer is a multistep process involving structural alterations of the epithelial mucosa, from dysplasia (LDy) to invasive carcinoma. In this study, we define new biomarkers, prognostic for malignant transformation, in patients affected by LDy. (2) Methods: We used targeted next-generation sequencing and immunohistochemical analysis to define the mutational and immunological landscape of 15 laryngeal dysplasia progressing to invasive cancer (progressing dysplasia), as well as 31 cases of laryngeal dysplasia that did not progress to carcinoma (non-progressing dysplasia). Two pathologists independently analyzed the presence of tumor-infiltrating lymphocytes in LDy pre-embedded paraffin-fixed specimens. The RNA-based next-generation sequencing panel OIRRA was used to evaluate the expression of 395 genes related to immune system activation. (3) Results: High TILs are significantly correlated with a higher risk of malignant transformation. The non-brisk pattern was significantly associated with an 86% reduced risk of malignant progression (OR = 0.16, 95% CI: 0.03-0.5,

Identifiants

pubmed: 36831458
pii: cancers15041117
doi: 10.3390/cancers15041117
pmc: PMC9954731
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministero della Salute
ID : Ricerca Corrente

Références

J Natl Cancer Inst. 1989 Dec 20;81(24):1879-86
pubmed: 2593165
Cancer Immunol Immunother. 2013 Aug;62(8):1347-57
pubmed: 23685782
J Cell Physiol. 2014 Jan;229(1):68-78
pubmed: 23765988
Cancers (Basel). 2021 Mar 23;13(6):
pubmed: 33806868
Sci Rep. 2020 Oct 27;10(1):18327
pubmed: 33110100
Pathol Res Pract. 2020 Jan;216(1):152793
pubmed: 31870593
Breast Cancer Res Treat. 2020 Jun;181(3):541-551
pubmed: 32350677
Eur J Immunol. 2010 Dec;40(12):3347-57
pubmed: 21110318
Eur Arch Otorhinolaryngol. 2015 Jul;272(7):1719-24
pubmed: 25749613
Surg Pathol Clin. 2017 Mar;10(1):15-33
pubmed: 28153131
JAMA Netw Open. 2021 Sep 1;4(9):e2126337
pubmed: 34550383
Immunology. 2013 Oct;140(2):259-72
pubmed: 23789844
Oncotarget. 2016 Nov 15;7(46):76087-76100
pubmed: 27738319
Laryngoscope. 2022 Jul;132(7):1334-1339
pubmed: 34415055
Cancer. 1996 Apr 1;77(7):1303-10
pubmed: 8608507
Cancers (Basel). 2022 Mar 28;14(7):
pubmed: 35406495
Lab Invest. 1996 Jan;74(1):43-7
pubmed: 8569196
Stem Cells. 2010 Aug;28(8):1435-45
pubmed: 20572012
Stem Cell Reports. 2014 Nov 11;3(5):691-8
pubmed: 25316190
Front Immunol. 2020 Apr 17;11:721
pubmed: 32362900
Front Physiol. 2014 Mar 28;5:114
pubmed: 24734023
Exp Cell Res. 2011 Mar 10;317(5):613-9
pubmed: 21376174
Neoplasia. 2009 Dec;11(12):1329-39
pubmed: 20019841
Mol Cancer Res. 2011 Feb;9(2):161-72
pubmed: 21205837
Front Cell Dev Biol. 2021 Jul 07;9:687322
pubmed: 34307366
Elife. 2020 Feb 14;9:
pubmed: 32057296
Am J Otolaryngol. 2021 Mar-Apr;42(2):102861
pubmed: 33445041
Clin Cancer Res. 2000 Feb;6(2):347-52
pubmed: 10690509
Front Immunol. 2022 Sep 02;13:954567
pubmed: 36119104
J Cancer. 2020 Jan 1;11(5):1182-1194
pubmed: 31956364
Eur Arch Otorhinolaryngol. 2000;257(4):227-31
pubmed: 10867840
Biomedicines. 2021 Jan 04;9(1):
pubmed: 33406809
Eur Arch Otorhinolaryngol. 2007 May;264(5):499-504
pubmed: 17377801
Cancer Cell Int. 2021 Jan 20;21(1):59
pubmed: 33472637
Int Immunol. 1994 May;6(5):701-9
pubmed: 7521667
PLoS One. 2016 Feb 29;11(2):e0148764
pubmed: 26928328
Chin J Cancer Res. 2020 Feb;32(1):18-25
pubmed: 32194301
Cancer Res. 2007 Dec 15;67(24):11721-31
pubmed: 18089802
Cancer Res. 1996 Jun 1;56(11):2488-92
pubmed: 8653682
Head Neck. 2016 Apr;38 Suppl 1:E2284-90
pubmed: 26268427
Laryngoscope. 2015 Sep;125(9):2143-56
pubmed: 26013745
Nature. 1985 Mar 21-27;314(6008):266-8
pubmed: 3920526
Sci Rep. 2021 Jul 15;11(1):14556
pubmed: 34267246
Immunol Rev. 2018 Jan;281(1):57-61
pubmed: 29247996

Auteurs

Francesco Chu (F)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Fausto Maffini (F)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Daniela Lepanto (D)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Davide Vacirca (D)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Sergio Vincenzo Taormina (SV)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Rita De Berardinis (R)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Sara Gandini (S)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.

Silvano Vignati (S)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.

Alberto Ranghiero (A)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.

Alessandra Rappa (A)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.

Susanna Chiocca (S)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.

Massimo Barberis (M)

Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Marta Tagliabue (M)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.

Mohssen Ansarin (M)

Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Classifications MeSH